Trial Profile
A Double Blind, Cross-Over Study Comparing Aerosolized Lucinactant and Vehicle on Mucociliary Clearance for Cystic Fibrosis Lung Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Dec 2018
Price :
$35
*
At a glance
- Drugs Sinapultide (Primary)
- Indications Cystic fibrosis
- Focus Pharmacodynamics
- 18 May 2014 New trial record
- 02 Sep 2010